Alpha Biophama is a clinical stage biopharmaceutical company.
Alpha Biopharma is supported by the domestic and foreign famous funds, and committed to the clinical development of global innovator drug. The company collaborates with the large-scale international drug companies to ensure the preliminary research and development of the product is solid and reliable. By using the powerful scientific consultant and management team and developing the optimization strategy for innovative drug development, the company lay emphasis on the multi-dimensional layout: research and development/market/intellectual property protection. The specifictest operation and business development are collaborated with the international/domestic topCRO/CMO/hospital/institute, and ensure the program is rational and orderly implementation by using the company’s impeccable project management system.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 15, 2021 | Series B | $25M | 1 | — | — | Detail |
Jun 19, 2018 | Series A | $37M | 3 | Qiming Venture Partners | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Qiming Venture Partners | — | Series B |
LYZZ Capital | — | Series A |
TF Capital | — | Series A |